• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定甲状腺微小乳头状癌患者甲状腺切除术和淋巴结清扫术的最佳范围。

Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma.

作者信息

Feng Jia-Wei, Pan Hua, Wang Lei, Ye Jing, Jiang Yong, Qu Zhen

机构信息

The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, China.

出版信息

Front Endocrinol (Lausanne). 2019 Jun 19;10:363. doi: 10.3389/fendo.2019.00363. eCollection 2019.

DOI:10.3389/fendo.2019.00363
PMID:31275239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6593058/
Abstract

The optimal extent of surgery, including lymph node dissection, remains controversial in papillary thyroid microcarcinoma (PTMC). Determining risk factors of central lymph node metastasis (CLNM) and recurrence-free survival (RFS) may help surgeons determine individualized surgery. A total of 353 patients with PTMC were retrospectively analyzed, including 263 with overt PTMC and 90 with incidental PTMC. The recurrence rates between different extents of thyroidectomy were compared. The relationship between CLNM and clinicopathologic factors was analyzed. The Cox regression model was used to determine the risk factors for RFS. Lobectomy/total thyroidectomy (TT) with central neck dissection (CND) was performed in 263 overt PTMC patients, and lobectomy/partial thyroidectomy was performed in 90 incidental PTMC patients. In 263 overt PTMC patients, 93 (26.3%) had CLNM only and 13 (3.7%) had both CLNM and lateral lymph node metastases (LLNM). Multifocal PTMC patients who underwent lobectomy had a higher rate of thyroid bed and lymph node recurrence than patients who underwent TT ( < 0.05). Independent predictors for CLNM were age <45 years, tumor size >5 mm and presence of extrathyroidal extension (ETE). Tumor size >5 mm, multifocality, presence of ETE, presence of CLNM, and presence of LLNM were the significant factors related to the RFS. Fine-needle aspiration biopsy is advised to distinguish incidental PTMC from the benign nodules. For multifocal PTMC patients, TT should be performed to reduce recurrence. Routine prophylactic CND can be recommended in PTMC patients with independent risk factors of CLNM. Aggressive surgery and close follow-up are essential for patients with risk factors of RFS.

摘要

在甲状腺微小乳头状癌(PTMC)中,包括淋巴结清扫在内的手术最佳范围仍存在争议。确定中央淋巴结转移(CLNM)和无复发生存期(RFS)的危险因素可能有助于外科医生确定个体化手术方案。对353例PTMC患者进行回顾性分析,其中包括263例显性PTMC患者和90例偶然发现的PTMC患者。比较了不同甲状腺切除范围的复发率。分析了CLNM与临床病理因素之间的关系。采用Cox回归模型确定RFS的危险因素。263例显性PTMC患者行叶切除术/全甲状腺切除术(TT)加中央区淋巴结清扫(CND),90例偶然发现的PTMC患者行叶切除术/部分甲状腺切除术。在263例显性PTMC患者中,93例(26.3%)仅发生CLNM,13例(3.7%)同时发生CLNM和侧方淋巴结转移(LLNM)。行叶切除术的多灶性PTMC患者甲状腺床和淋巴结复发率高于行TT的患者(<0.05)。CLNM的独立预测因素为年龄<45岁、肿瘤大小>5mm和存在甲状腺外侵犯(ETE)。肿瘤大小>5mm、多灶性、存在ETE、存在CLNM和存在LLNM是与RFS相关的重要因素。建议行细针穿刺活检以区分偶然发现的PTMC与良性结节。对于多灶性PTMC患者,应行TT以降低复发率。对于具有CLNM独立危险因素的PTMC患者,可推荐常规预防性CND。对于具有RFS危险因素的患者,积极的手术和密切的随访至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94c/6593058/abcdd1ef51bf/fendo-10-00363-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94c/6593058/ab196eeffce5/fendo-10-00363-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94c/6593058/55f085b1c1c3/fendo-10-00363-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94c/6593058/abcdd1ef51bf/fendo-10-00363-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94c/6593058/ab196eeffce5/fendo-10-00363-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94c/6593058/55f085b1c1c3/fendo-10-00363-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d94c/6593058/abcdd1ef51bf/fendo-10-00363-g0003.jpg

相似文献

1
Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma.确定甲状腺微小乳头状癌患者甲状腺切除术和淋巴结清扫术的最佳范围。
Front Endocrinol (Lausanne). 2019 Jun 19;10:363. doi: 10.3389/fendo.2019.00363. eCollection 2019.
2
Significance of multifocality in papillary thyroid carcinoma.多灶性在甲状腺乳头状癌中的意义。
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
3
Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.临床淋巴结阴性甲状腺微小乳头状癌患者中央淋巴结转移危险因素的识别及预防性中央区颈淋巴结清扫对分期迁移和风险分层影响的评估
Bull Cancer. 2017 Jun;104(6):516-523. doi: 10.1016/j.bulcan.2017.03.005. Epub 2017 May 2.
4
The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.中国广东省甲状腺微小乳头状癌患者淋巴结转移及术后复发的临床病理预测因素分析——一项多中心回顾性研究
Int J Clin Exp Pathol. 2017 Sep 1;10(9):9735-9743. eCollection 2017.
5
Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection.预测甲状腺微小乳头状癌中央区和侧方淋巴结转移的临床病理特征:对66例行中央区和侧方淋巴结清扫病例的分析
Mol Clin Oncol. 2017 Jan;6(1):49-55. doi: 10.3892/mco.2016.1085. Epub 2016 Nov 18.
6
Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.根据中央淋巴结转移风险评分模型和复发预测因素管理 cN0 甲状腺微小乳头状癌患者。
J Endocrinol Invest. 2020 Dec;43(12):1807-1817. doi: 10.1007/s40618-020-01326-1. Epub 2020 Jun 18.
7
Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.甲状腺微小乳头状癌侧颈部淋巴结转移:5241 例随访患者研究。
Endocrine. 2024 Feb;83(2):414-421. doi: 10.1007/s12020-023-03486-5. Epub 2023 Aug 18.
8
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌中央区淋巴结和侧颈区淋巴结转移的因素。
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
9
Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?所有甲状腺微小乳头状癌都应考虑行中央区淋巴结清扫吗?
Asian J Surg. 2016 Oct;39(4):197-201. doi: 10.1016/j.asjsur.2015.02.006. Epub 2015 Apr 22.
10
Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.高位甲状腺微小乳头状癌是侧颈部淋巴结转移的危险因素。
Ann Surg Oncol. 2019 Nov;26(12):3992-4001. doi: 10.1245/s10434-019-07587-2. Epub 2019 Jul 1.

引用本文的文献

1
Impact of fellowship training for specialists on thyroidectomy outcomes of patients with thyroid cancer.专科医师培训对甲状腺癌患者甲状腺切除术结局的影响。
Sci Rep. 2024 Apr 19;14(1):9033. doi: 10.1038/s41598-024-59864-0.
2
Predicting Extrathyroidal Extension in Papillary Thyroid Carcinoma Using a Clinical-Radiomics Nomogram Based on B-Mode and Contrast-Enhanced Ultrasound.基于B超和超声造影的临床-影像组学列线图预测甲状腺乳头状癌的甲状腺外侵犯
Diagnostics (Basel). 2023 May 13;13(10):1734. doi: 10.3390/diagnostics13101734.
3
Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.

本文引用的文献

1
Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis.中央区颈部淋巴结临床未受累的甲状腺乳头状癌预防性中央区颈部淋巴结清扫术:一项系统评价和Meta分析
World J Surg. 2018 Sep;42(9):2846-2857. doi: 10.1007/s00268-018-4547-4.
2
Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis.评估预防性中央区颈淋巴结清扫术联合全甲状腺切除术治疗cN0期乳头状甲状腺癌的有效性:一项更新的荟萃分析。
Eur J Surg Oncol. 2017 Nov;43(11):1989-2000. doi: 10.1016/j.ejso.2017.07.008. Epub 2017 Aug 3.
3
临床隐匿性甲状腺微小乳头状癌中央区淋巴结转移的临床病理预测因素:系统评价和荟萃分析。
World J Surg Oncol. 2022 Apr 1;20(1):106. doi: 10.1186/s12957-022-02573-7.
4
Optimal Surgical Extent in Patients with Unilateral Multifocal Papillary Thyroid Carcinoma.单侧多灶性乳头状甲状腺癌患者的最佳手术范围
Cancers (Basel). 2022 Jan 15;14(2):432. doi: 10.3390/cancers14020432.
5
Risk Factors of Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma and the Value of Sentinel Lymph Node Biopsy.甲状腺微小乳头状癌中央区淋巴结转移的危险因素及前哨淋巴结活检的价值
Front Surg. 2021 Jun 16;8:680493. doi: 10.3389/fsurg.2021.680493. eCollection 2021.
6
Extent of Surgery and the Prognosis of Unilateral Papillary Thyroid Microcarcinoma.单侧甲状腺微小乳头状癌的手术范围与预后。
Front Endocrinol (Lausanne). 2021 Jun 16;12:655608. doi: 10.3389/fendo.2021.655608. eCollection 2021.
7
Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌颈淋巴结转移风险术前预测列线图
Front Endocrinol (Lausanne). 2021 Mar 31;12:613974. doi: 10.3389/fendo.2021.613974. eCollection 2021.
8
Application of Machine Learning Algorithms to Predict Central Lymph Node Metastasis in T1-T2, Non-invasive, and Clinically Node Negative Papillary Thyroid Carcinoma.应用机器学习算法预测T1-T2期、非侵袭性且临床淋巴结阴性的乳头状甲状腺癌的中央淋巴结转移
Front Med (Lausanne). 2021 Mar 9;8:635771. doi: 10.3389/fmed.2021.635771. eCollection 2021.
9
Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma.甲状腺乳头状癌中Delphian淋巴结转移的临床意义
Gland Surg. 2021 Jan;10(1):73-82. doi: 10.21037/gs-20-521.
10
Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma.甲状腺微小乳头状癌中央区淋巴结转移的预测因素
World J Clin Cases. 2020 Apr 26;8(8):1350-1360. doi: 10.12998/wjcc.v8.i8.1350.
Galectin-3 Performance in Histologic a Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis.
半乳糖凝集素-3在甲状腺结节组织学和细胞学评估中的表现:一项系统评价和荟萃分析。
Int J Mol Sci. 2017 Aug 11;18(8):1756. doi: 10.3390/ijms18081756.
4
Detection of Malignancy Among Suspicious Thyroid Nodules <1 cm on Ultrasound with Various Thyroid Image Reporting and Data Systems.超声检查发现直径<1cm 的甲状腺结节,不同甲状腺影像报告和数据系统对甲状腺良恶性结节的诊断效能。
Thyroid. 2017 Oct;27(10):1307-1315. doi: 10.1089/thy.2017.0034. Epub 2017 Sep 19.
5
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.1974 - 2013年美国甲状腺癌发病率和死亡率趋势
JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.
6
Independent Risk Factors Predicting Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.预测甲状腺微小乳头状癌中央淋巴结转移的独立危险因素
Horm Metab Res. 2017 Mar;49(3):201-207. doi: 10.1055/s-0043-101917. Epub 2017 Mar 28.
7
Treatment decision making in early-stage papillary thyroid cancer.早期甲状腺乳头状癌的治疗决策。
Psychooncology. 2018 Jan;27(1):61-68. doi: 10.1002/pon.4383. Epub 2017 Feb 27.
8
Short-term Follow-up US Leads to Higher False-positive Results Without Detection of Structural Recurrences in PTMC.短期超声随访导致更高的假阳性结果,且未检测到甲状腺微小癌的结构复发。
Medicine (Baltimore). 2016 Jan;95(1):e2435. doi: 10.1097/MD.0000000000002435.
9
Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review].关于低风险甲状腺微小乳头状癌主动监测的见解与临床问题[综述]
Endocr J. 2016 Apr 25;63(4):323-8. doi: 10.1507/endocrj.EJ15-0637. Epub 2015 Dec 2.
10
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.